Brief: AxoGen Q2 Revenue USD 47.9 Million Vs. IBES Estimate USD 43.4 Million
08/08/2024 12:00
Aug 08 (Reuters) - AxoGen Q2 adjusted EBITDA USD 5.6 million vs. IBES estimate USD 2.49 million. * Q2 adjusted net income USD 2 million vs. IBES estimate USD -1.66 million * Q2 gross margin 73.8% * Q2 net income USD -1.9 million * outlook FY revenue USD 182-186 million